Facebook Booms, Merck, Pfizer Earnings Loom

NEW YORK ( TheStreet) -- Earnings season peaked this week in terms of the number of stocks that reported. On July 23 I profiled nine stocks that reported results on July 24 in Boeing, Caterpillar, Facebook Earnings Ahead . Seven beat their EPS estimates and only one missed.

On July 24 I profiled 13 stocks in Amazon, GM and 3M Earnings Preview. These stocks reported earnings results Thursday, and on Monday I will provide a scorecard for these names. I will also profile eight stocks that report their earnings on Wednesday.

Today I provide my buy-and-trade data for five stocks that report results on Tuesday.

Here's my scorecard for the July 24 field of stocks:

Akamai Tech ( AKAM) ($45.19) matched estimates earning 37 cents a share. The stock opened lower Thursday with a low at 42.40. Buy-and-trade investors who had GTC Limit Orders to buy weakness to my monthly value level is $43.27 were filled at the opening price at $42.50 and the stock popped to $45.59.

Boeing ( BA) ($106.70) beat estimates by 9 cents earning $1.67 a share. Boeing reported premarket on July 24 and traded up to a new multi-year high at $109.49 at the open. Buy-and-trade investors with a GTC Limit Order to sell did so as $109.49 is my semiannual risky level. My monthly value level is $103.24 with a weekly pivot at $105.72 and semiannual risky level at $109.49.

Caterpillar ( CAT) ($82.14) missed estimates by 26 cents earning $1.45 a share. This stock disappointed once again and traded to a low of $81.35 on Thursday. Failing to hold the 50-day simple moving average at $84.91 lead to a test of this week's pivot at $82.80.

Citrix Systems ( CTXS) ($67.98) beat estimates by 2 cents earning 47 cents a share. The stock opened Thursday with a high at $70.66 then fell to $66.98. Buy-and-trade investors with a GTC Limit Order to sell strength to my annual risky level were filled at the opening price at $70.45. Support is the 200-day SMA at $66.44.

EMC ( EMC) ($26.75) beat estimates by a penny earning 35 cents a share premarket on Wednesday. The stock spiked to $27.34 then declined to $26.31 on Thursday. My monthly value level is $23.59 with a weekly pivot at $25.75 and semiannual risky level at $32.66.

If you liked this article you might like

'Date' These Potential Biotech Winners

'Date' These Potential Biotech Winners

The 10 Stocks America's Biggest Hedge Funds Are Dumping Like Crazy

Why You Keep Cash on Hand; No Downside Conviction -- Jim Cramer's Top Thoughts